Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

AI creatives with access to Google’s Veo 2 text-to-video tool say it’s another “leap forward” for video generation Veo 2 ...

The order, signed in October 2023, required companies building powerful AI systems to share their safety test results with ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Google DeepMind Chief Operations Officer Lila Ibrahim discussed the changes that the Trump administration may bring, ...

The headlines are the Galaxy S25 line-up, but the hardware is powered by Samsung's ambition to develop an AI ecosystem ...

With "Mind Evolution" LLMs can use search and genetic algorithms to generate and combine different solutions and find the optimal one.

The company fulfilled requests from Israel’s military for more access to AI tools as it sought to compete with Amazon, ...

Google DeepMind AI for Science Scholarships are now available, offering African students the opportunity to pursue ...

Business Insider's diary takes you behind the scenes on day three of the World Economic Forum in Davos.